Sameer Dewan - 29 Feb 2024 Form 3 Insider Report for Genpact LTD (G)

Role
Senior Vice President
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Sameer Dewan
Issuer symbol
G
Transactions as of
29 Feb 2024
Net transactions value
$0
Form type
3
Filing time
11 Mar 2024, 16:53:22 UTC
Next filing
15 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding G Common Shares 54,875 29 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding G Employee Stock Option (Right to Buy) 29 Feb 2024 Common Shares 42,880 $44.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 4,584 unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (the "Plan"), of which 50% will vest on January 10, 2025 and the remaining 50% will vest on January 10, 2026, subject to the reporting person's continued service through each vesting date, (ii) 12,174 shares underlying performance share units (PSUs) granted under the Plan on March 20, 2022, and (iii) 1,654 shares acquired under the Genpact Employee Stock Purchase Plan. The PSU grant was subject to performance conditions which have been satisfied, and each PSU and RSU represents the contingent right to receive one common share. The 2022 PSU grant will vest on January 10, 2025, subject to the reporting person's continued service through such date.
F2 The option vested 50% on January 10, 2024 and the remaining 50% vests on January 10, 2026, subject to the reporting person's continued service through such date.

Remarks:

Exhibit 24.1 - Power of Attorney